MT1-MMP (via BT1718)

E1266368 UNEXPLORED

MT1-MMP (via BT1718) is a membrane-bound matrix metalloproteinase exploited by the Bicycle Therapeutics drug candidate BT1718 as a tumor-targeting antigen for selective delivery of cytotoxic payloads to cancer cells.

All labels observed (1)

Label Occurrences
MT1-MMP (via BT1718) canonical 1

How this entity was disambiguated

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Bicycle Therapeutics targets MT1-MMP (via BT1718)